Molecular Mechanisms of Asthma
哮喘的分子机制
基本信息
- 批准号:7204126
- 负责人:
- 金额:$ 127.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-01 至 2008-08-29
- 项目状态:已结题
- 来源:
- 关键词:A MouseAbsenteeismAbsenteeism at workAccountingAcuteAddressAdultAdvisory CommitteesAffectAgeAirAllergensAllergicAmericanAnimalsAntibodiesAntigen PresentationAntigen-Presenting CellsAntigensApoptosisApoptoticAsthmaAttentionAwardBTBR MouseBindingBiological ModelsBiologyBreathingBreedingBronchoalveolar LavageBronchoconstrictor AgentsCD28 geneCD4 Positive T LymphocytesCaringCatalogingCatalogsCell CycleCell LineCell physiologyCellsCharacteristicsChicagoChildCholinergic AgentsChronicChronic DiseaseCircadian RhythmsClassClassificationClinicalClinical ResearchClinical TrialsCollaborationsCommunicationCommunitiesCompanionsComplement Factor BCritical CareCultured CellsDataDatabasesDevelopmentDisciplineDiseaseDisruptionDoctor of MedicineDoctor of PhilosophyDoxycyclineEatingEffector CellElevationEmployee StrikesEnsureEpithelialEpithelial CellsEpitheliumEquilibriumEthylnitrosoureaEvaluationExhibitsExtrinsic asthmaFamilyFamily memberFertilityFibrosisFoundationsFunctional disorderFundingFutureGene ExpressionGenerationsGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseGenetic TranscriptionGenetic VariationGenomeGenotypeGoalsGoblet CellsGrowth FactorGrowth Factor ReceptorsHistocompatibilityHomeostasisHospitalizationHumanHuman VolunteersHypersensitivityHypertrophyIgEImProvImmuneImmune responseImmunoglobulin AImmunologyImmunotherapyIncidenceIndividualInduced MutationInfiltrationInflammationInflammatoryInflammatory ResponseInterventionInvasiveInvestigationJUN geneJointsLeadLearningLifeLigandsLigationLungLymphoidMAPK14 geneMaintenanceMalignant NeoplasmsMapsMeasurementMechanicsMediatingMelanocytic nevusMemoryMethodsMinorModalityModelingModificationMole the mammalMolecularMolecular BiologyMolecular GeneticsMouse StrainsMusMuscle CellsMutant Strains MiceMutationNeurobiologyNitrosourea CompoundsNumbersObstructionOutcomeOutpatientsParentsPathologicPathologic ProcessesPathologyPathway interactionsPatientsPenetrancePerformancePersonal SatisfactionPharmaceutical PreparationsPhenotypePhysiciansPhysiologicalPlayPoint MutationPopulationPrevalencePreventionProcessProductionProductivityPromoter RegionsRangeRecording of previous eventsRecruitment ActivityRegulationReportingResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsResearch TrainingResistanceResourcesRoleSamplingSchoolsScientistScreening procedureSeminalSeriesSerumServicesSeveritiesSideSignal PathwaySignal TransductionSmooth Muscle MyocytesSonSpecimenStimulusStructureStudy SubjectSumSurfaceSurface AntigensSusceptibility GeneSymptomsT-Cell ActivationT-LymphocyteTNFRSF6 geneTailTechniquesTechnologyTestingTh2 CellsTherapeuticTherapeutic InterventionThinkingTimeTissuesTransforming Growth FactorsTransgenic MiceTransgenic ModelTransplantationTumor Necrosis Factor-BetaUnited StatesUnited States National Institutes of HealthUniversitiesVariantVisitWeaningYangairway epitheliumairway hyperresponsivenessairway inflammationairway remodelingallergic airway diseaseallergic airway inflammationanti-IgEasthmatic airwayatopybasecell typecholinergiccostcost effectivenesscrosslinkcytokinedayeosinophilexperiencefascinategene interactiongene therapygenetic analysisgenetic linkage analysisgenetic pedigreehuman subjectimprovedin vivoinner cityinsightinterestkindredmast cellmortalitymutantnovelnovel strategiesnovel therapeuticspreventprogramsquantumreceptorresearch studyrespiratoryrespiratory smooth muscleresponsestress-activated protein kinase 1successtherapeutic targetvolunteer
项目摘要
DESCRIPTION (provided by applicant):
The overall objective of this AADRC Program is to evaluate the cellular and molecular basis for asthma, in order to identify novel strategies for eventual therapeutic intervention. To achieve this goal, four research projects are proposed to address three interrelated facets of the asthmatic process: immune mechanisms that underlie chronic airway inflammation, apoptotic disruption of airway epithelial integrity, and genetic predispositions to atopy and to airway constrictor hyper-responsiveness. The comprehensive, mechanistic evaluations proposed require special expertise in the fields of immunology, cell signaling, molecular biology, and molecular genetics. An important feature of this AADRC proposal is that scientists from outside the traditional pulmonary community join with senior airways investigators to form a cohesive, interactive research program that incorporates a wide range of new perspectives, technologies, and approaches.
Project 1, Role of ICOS Expression Level in Atopy, addresses how genetic variations in the human ICOS gene that have been associated with atopy influence ICOS expression levels, and how these in turn modulate T cell function and allergic airway inflammation. Project 2, Role of Lymphotoxin in IgE Deficiency-induced Airway Inflammation, evaluates how reduced IgE levels in lymphotoxin-deficient mice lead to Th1-dominant airway inflammation and structural changes that mimic chronic severe asthma, and prompts the novel idea that a subset of asthmatics may have Th1-dominant, rather than Th2-dominant, airway inflammation. Project 3, Genetic Basis of Airway Hyper-responsiveness, will identify the mutation(s) and physiological mechanisms that have caused native airway cholinergic hyper-responsiveness in recently established kindred of chemically mutagenized mice. Project 4, Role of TGF-B in Protection Against Airway Epithelial Cell Apoptosis in Asthma, tests the molecular mechanisms by which this growth factor protects normal, but not asthmatic, airway epithelium from apoptosis. These projects form a research program whose sum is greater than its parts, for: (i) they follow a logical thematic progression from basic allergic and non-allergic immune mechanisms in airway inflammation, into epithelial barrier function that constitutes the first line of defense against immune activation, and into identification of gene variations responsible for cardinal features of asthma; (ii) they benefit from considerable exchange of expertise and commonality of approach; and (iii) they take advantage of three common core organizations (Mouse Breeding, Human Subject Recruitment, and Administration) that enhance research efficiency and productivity. Data derived from these collaborative studies will yield new insights into the cellular and molecular mechanisms underlying asthma, and therefore should suggest strategies for novel therapeutic intervention.
描述(由申请人提供):
该AADRC计划的总体目的是评估哮喘的细胞和分子基础,以确定最终治疗干预的新策略。为了实现这一目标,提出了四个研究项目,以解决哮喘过程的三个相互关联的方面:慢性气道炎症,气道上皮完整性的凋亡破坏以及遗传性倾向的免疫机制,以及对ATOPY的遗传倾向和Airway collation缩合。提出的全面的机械评估需要在免疫学,细胞信号传导,分子生物学和分子遗传学领域的特殊专业知识。该AADRC提案的一个重要特征是,来自传统肺部社区之外的科学家与高级航空公司调查人员一起组成了一个有凝聚力的互动研究计划,该计划结合了各种新的观点,技术和方法。
项目1(ICOS表达水平在特应性中的作用)解决了与特应性的人类ICOS基因中的遗传变异如何影响ICOS表达水平,以及这些如何调节T细胞功能和过敏性气道炎症。 Project 2, Role of Lymphotoxin in IgE Deficiency-induced Airway Inflammation, evaluates how reduced IgE levels in lymphotoxin-deficient mice lead to Th1-dominant airway inflammation and structural changes that mimic chronic severe asthma, and prompts the novel idea that a subset of asthmatics may have Th1-dominant, rather than Th2-dominant, airway inflammation.项目3(气道高反应性的遗传基础)将确定在最近确定的化学诱变小鼠中引起天然气道胆碱能超反应性的突变和生理机制。项目4,TGF-B在哮喘中防止气道上皮细胞凋亡的保护中的作用,测试了该生长因子保护正常但不能保护哮喘的气道上皮细胞免受凋亡的分子机制。这些项目构成了一个研究计划,其总和大于其部分,因为:(i)它们遵循气道炎症中基本过敏和非过敏性免疫机制的逻辑主题进展,转化为上皮屏障功能,构成了针对免疫激活的第一线,并构成了对基因的识别,是对基因的识别。 (ii)他们受益于大量的专业知识和方法的共同点; (iii)他们利用了提高研究效率和生产力的三个共同核心组织(小鼠育种,人类受试者招聘和管理)的优势。从这些协作研究中得出的数据将产生哮喘潜在的细胞和分子机制的新见解,因此应提出新型治疗干预的策略。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protective effector memory CD4 T cells depend on ICOS for survival.
- DOI:10.1371/journal.pone.0016529
- 发表时间:2011-02-18
- 期刊:
- 影响因子:3.7
- 作者:Moore TV;Clay BS;Ferreira CM;Williams JW;Rogozinska M;Cannon JL;Shilling RA;Marzo AL;Sperling AI
- 通讯作者:Sperling AI
Force fluctuation-induced relengthening of acetylcholine-contracted airway smooth muscle.
力波动引起乙酰胆碱收缩气道平滑肌的重新延长。
- DOI:10.1513/pats.200705-058vs
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Mitchell,RichardW;Dowell,MariaL;Solway,Julian;Lakser,OrenJ
- 通讯作者:Lakser,OrenJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julian Solway其他文献
Julian Solway的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julian Solway', 18)}}的其他基金
IRF4+ respiratory dendritic cells in type 2 inflammatory responses
IRF4呼吸树突状细胞在2型炎症反应中的作用
- 批准号:
10078845 - 财政年份:2017
- 资助金额:
$ 127.7万 - 项目类别:
TRANSLATIONAL RESEARCH AT THE UNIVERSITY OF CHICAGO
芝加哥大学的转化研究
- 批准号:
8366084 - 财政年份:2011
- 资助金额:
$ 127.7万 - 项目类别:
TRANSLATIONAL RESEARCH AT THE UNIVERSITY OF CHICAGO
芝加哥大学的转化研究
- 批准号:
8173808 - 财政年份:2010
- 资助金额:
$ 127.7万 - 项目类别:
相似海外基金
Improving Function and Reducing Opioid Use for Patients with Chronic Low Back Pain in Rural Communities through Improved Access to Physical Therapy using Telerehabilitation
通过远程康复改善物理治疗的可及性,改善农村社区慢性腰痛患者的功能并减少阿片类药物的使用
- 批准号:
10745146 - 财政年份:2023
- 资助金额:
$ 127.7万 - 项目类别:
Randomized Controlled Trial of Macrolide Therapy for Mycoplasma pneumoniae
大环内酯类药物治疗肺炎支原体的随机对照试验
- 批准号:
10620551 - 财政年份:2023
- 资助金额:
$ 127.7万 - 项目类别:
Beetroot Juice Supplement for Boosting Mucosal Immunity – The NO Cold Study
甜菜根汁补充剂可增强粘膜免疫力 — NO 感冒研究
- 批准号:
10645991 - 财政年份:2023
- 资助金额:
$ 127.7万 - 项目类别:
Heterogeneity in joint real-time and developmental influences of positive and negative social media experiences on socioemotional vulnerability and psychopathology across adolescence
积极和消极的社交媒体体验对青春期社会情感脆弱性和精神病理学的联合实时和发展影响的异质性
- 批准号:
10812927 - 财政年份:2023
- 资助金额:
$ 127.7万 - 项目类别:
Music mechanisms and technologies network: Integrative models to address pain through music
音乐机制和技术网络:通过音乐解决疼痛的综合模型
- 批准号:
10765327 - 财政年份:2023
- 资助金额:
$ 127.7万 - 项目类别: